Carotid stents reduce longitudinal movements within the vascular wall.

Arterial displacement atherosclerosis longitudinal sliding stent

Journal

Clinical hemorheology and microcirculation
ISSN: 1875-8622
Titre abrégé: Clin Hemorheol Microcirc
Pays: Netherlands
ID NLM: 9709206

Informations de publication

Date de publication:
14 Sep 2024
Historique:
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

Longitudinal Displacement (LD) is the relative motion of the intima-media upon adventitia of the arterial wall during the cardiac cycle, probably linked to atherosclerosis. It has a direction, physiologically first backward in its main components with respect to the arterial flow. Here, LD was investigated in various disease and in presence of a unilateral carotid stent. Carotid acquisitions were performed by ultrasound imaging on both body sides of 75 participants (150 Arteries). LD was measured in its percent quantity and direction. Obesity (p = 0.001) and carotid plaques (p = 0.01) were independently associated to quantity decrease of LD in the whole population. In a subgroup analysis, it was respectively 143% in healthy (n = 48 carotids), 129% (n = 34) in presence of cardiovascular risk factors, 121% (n = 20) in MACE patients, 119% (n = 24) in the carotid contralateral to a stent, 110% (n = 24) in carotids with stents. Regarding the direction of LD, in a subgroup analysis an inverted movement was identified in aged (p = 0.001) and diseased (p = 0.001) participants who also showed less quantity of LD (p = 0.001), but independently with age only (p = 0.002) in the whole population. This observational study suggests that LD within carotid wall layers is lower additively with ageing, cardiovascular risk factors, cardiovascular diseases, and stent. Even if stent is surely beneficial, these data might shed some light on stent restenosis, emphasising the need for interventional studies.

Sections du résumé

BACKGROUND UNASSIGNED
Longitudinal Displacement (LD) is the relative motion of the intima-media upon adventitia of the arterial wall during the cardiac cycle, probably linked to atherosclerosis. It has a direction, physiologically first backward in its main components with respect to the arterial flow. Here, LD was investigated in various disease and in presence of a unilateral carotid stent.
METHODS UNASSIGNED
Carotid acquisitions were performed by ultrasound imaging on both body sides of 75 participants (150 Arteries). LD was measured in its percent quantity and direction.
RESULTS UNASSIGNED
Obesity (p = 0.001) and carotid plaques (p = 0.01) were independently associated to quantity decrease of LD in the whole population. In a subgroup analysis, it was respectively 143% in healthy (n = 48 carotids), 129% (n = 34) in presence of cardiovascular risk factors, 121% (n = 20) in MACE patients, 119% (n = 24) in the carotid contralateral to a stent, 110% (n = 24) in carotids with stents. Regarding the direction of LD, in a subgroup analysis an inverted movement was identified in aged (p = 0.001) and diseased (p = 0.001) participants who also showed less quantity of LD (p = 0.001), but independently with age only (p = 0.002) in the whole population.
CONCLUSIONS UNASSIGNED
This observational study suggests that LD within carotid wall layers is lower additively with ageing, cardiovascular risk factors, cardiovascular diseases, and stent. Even if stent is surely beneficial, these data might shed some light on stent restenosis, emphasising the need for interventional studies.

Identifiants

pubmed: 39302358
pii: CH242357
doi: 10.3233/CH-242357
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Claudio Carallo (C)

Department of Chemical Engineering, Imperial College London, London, UK.
Department of Clinical and Experimental Medicine, Metabolic Diseases Unit, Magna Græcia University, Catanzaro, Italy.

Michela Destito (M)

Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, Italy.

Paolo Zaffino (P)

Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, Italy.

Chiara Caglioti (C)

Department of Clinical and Experimental Medicine, Metabolic Diseases Unit, Magna Græcia University, Catanzaro, Italy.

Vittorio Silipo (V)

Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, Italy.

Paolo Maria De Masi (PM)

Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, Italy.

Agostino Gnasso (A)

Department of Clinical and Experimental Medicine, Metabolic Diseases Unit, Magna Græcia University, Catanzaro, Italy.

Maria Francesca Spadea (MF)

Institute of Biomedical Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Classifications MeSH